Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
INO · NASDAQ · Pharmaceutical Preparations
$1.76+0.05 (+2.92%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Inovio Pharmaceuticals (INO) · oqro.io/stocks/INO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Alyeska Investment Group, L.P. cut its INO stake below 5% (3.3%)Source5%+ stake · Stake as of Nov 6, 2026 · Filed Nov 16, 2026
TANG CAPITAL MANAGEMENT, LLC now owns 10.0% of INO as a passive investorSource5%+ stake · Stake as of Jun 30, 2026 · Filed Nov 16, 2026
ADAR1 Capital Management, LLC now owns 7.4% of INO as a passive investorSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deep Track Capital, LP disclosed an increased position in INO for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deep Track Capital, LP disclosed a reduced position in INO for Q3 2024Source